Occupe actuellement des postes chez Novavax Inc and GlycoMimetics Inc
Position | Company | Period |
---|---|---|
Independent Director | Novavax Inc | 1 novembre 2018 - |
President, Chief Executive Officer, Co-Founder, Director | GlycoMimetics Inc | 1 janvier 2003 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2021-05-21 | 2021-05-19 |
Novavax Inc
(NVAX)
|
A Achat |
700
+33.3%
139,6497 748 USD |
700 +33.3% | 139,64 | 97 748 USD | |
2020-12-30 | 2020-12-28 |
GlycoMimetics Inc
(GLYC)
|
VP Vente planifiée |
84 176
-19.1%
3,91329 128 USD |
84 176 -19.1% | 3,91 | 329 128 USD | |
2019-03-28 | 2019-03-27 |
Novavax Inc
(NVAX)
|
A Achat |
22 000
+inf%
0,5311 656 USD |
22 000 +inf% | 0,53 | 11 656 USD | |
2019-03-28 | 2019-03-27 |
Novavax Inc
(NVAX)
|
A Achat |
22 000
+inf%
0,5311 656 USD |
22 000 +inf% | 0,53 | 11 656 USD | |
2019-03-28 | 2019-03-27 |
Novavax Inc
(NVAX)
|
A Achat |
42 000
+inf%
0,5322 252 USD |
42 000 +inf% | 0,53 | 22 252 USD |